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Abstract
Background: Nitric oxide (NO) and carbon monoxide (CO) in exhaled breath are considered
obtainable biomarkers of physiologic mechanisms. Therefore, obtaining their measures simply, non-
invasively, and repeatedly, is of interest, and was the purpose of the current study.
Methods: Expired NO (ENO) and CO (ECO) were measured non-invasively using a gas micro-
analyzer on several strains of mice (C57Bl6, IL-10-/-, A/J, MKK3-/-, JNK1-/-, NOS-2-/- and NOS-3-/-)
with and without allergic airway inflammation (AI) induced by ovalbumin systemic sensitization and
aerosol challenge, compared using independent-sample t-tests between groups, and repeated
measures analysis of variance (ANOVA) within groups over time of inflammation induction. ENO
and ECO were also measured in C57Bl6 and IL-10-/- mice, ages 8–58 weeks old, the relationship of
which was determined by regression analysis. S-methionyl-L-thiocitrulline (SMTC), and tin
protoporphyrin (SnPP) were used to inhibit neuronal/constitutive NOS-1 and heme-oxygenase,
respectively, and alter NO and CO production, respectively, as assessed by paired t-tests.
Methacholine-associated airway responses (AR) were measured by the enhanced pause method,
with comparisons by repeated measures ANOVA and post-hoc testing.
Results: ENO was significantly elevated in naïve IL-10-/- (9–14 ppb) and NOS-2-/- (16 ppb) mice as
compared to others (average: 5–8 ppb), whereas ECO was significantly higher in naïve A/J, NOS-3-/
- (3–4 ppm), and MKK3-/- (4–5 ppm) mice, as compared to others (average: 2.5 ppm). As compared
to C57Bl6 mice, AR of IL-10-/-, JNK1-/-, NOS-2-/-, and NOS-3-/- mice were decreased, whereas they
were greater for A/J and MKK3-/- mice. SMTC significantly decreased ENO by ~30%, but did not
change AR in NOS-2-/- mice. SnPP reduced ECO in C57Bl6 and IL-10-/- mice, and increased AR in
NOS-2-/- mice. ENO decreased as a function of age in IL-10-/- mice, remaining unchanged in C57Bl6
mice.
Conclusion: These results are consistent with the ideas that: 1) ENO is associated with mouse
strain and knockout differences in NO production and AR, 2) alterations of ENO and ECO can be
measured non-invasively with induction of allergic AI or inhibition of key gas-producing enzymes,
and 3) alterations in AR may be dependent on the relative balance of NO and CO in the airway.
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Background
Nitric oxide (NO) and carbon monoxide (CO) are small
gaseous molecules produced physiologically in minute
quantities, and are known to have significant physiologic
effects, such as vasodilation and bronchodilation [1-5].
NO is produced by nitric oxide synthase (NOS), an
enzyme present in numerous cells; the levels and activity
of one inducible isoform (NOS-2) can be significantly
modulated upward, by stresses such as inflammation
[6,7]. Similarly, CO is produced by heme-oxygenase
(HO), a ubiquitous enzyme within the body, and like
NOS-2, HO-1 is an isoform of HO that can be upregulated
by cellular stresses [8].
Recent technologies have allowed measurement of NO
and CO within a variety of gaseous and liquid media,
which has sparked interest in non-invasive assessments of
their levels in expired gas. The findings that humans with
asthma have elevated exhaled NO (ENO) which rises fur-
ther with antigen challenge and asthmatic exacerbations
[9], and which declines with anti-inflammatory therapy
such as inhaled steroids [10], has established an associa-
tion between ENO and airway inflammation, although the
precise nature of the association remains unclear Simi-
larly, increased exhaled CO (ECO) is associated with
asthma and airway inflammation [11], and can be
decreased with inhaled and oral steroids [12,13],
although the association between ECO and asthma is less
clear than that of ENO [14,15], and may be dependent on
asthma severity [16]. In furthering the understanding of
the relationship of ENO and ECO to lung function and air-
way inflammation, studies in which certain inflamma-
tion-modulating factors are lacking or suppressed, are of
interest. Mice with genetically targeted deletions of these
factors provide an opportunity to study their role in the
determination of ENO and ECO, in association with airway
inflammation and responsiveness.
Some prior studies have evaluated ENO and ECO in mice
and rats using various techniques of expired gas collec-
tion, and including more invasive approaches, such as
sampling collected gas from tracheostomy tubes during
mechanical ventilation [17], and non-invasive
approaches such as sampling expired gas within a flow-
through chamber setup [18], with mild to moderate
restraint [19]. Simple, non-invasive approaches have con-
siderable appeal, because they allow repetitive sampling
of unanesthetized individuals, e.g., with the development
of inflammation and the potential alteration of lung func-
tion with experimental manipulations
Therefore, the purpose of the present study was to assess
ENO and ECO using a simplified, non-invasive technique in
spontaneously-breathing unanesthetized mice, in associa-
tion with non-invasive assessments of airway responses
(AR). Stock C57Bl6 and A/J mouse strains were studied, as
well as those having targeted deletion of a critical inflam-
mation-associated interleukin (IL)-10, cellular enzymes
thought to be important in airway function (NOS-2 and
NOS-3), and protein kinases mitogen-activated kinase
kinase (MKK)-3, and c-jun activated kinase (JNK)1 which
are known to mediate aspects of allergic AI and AR. The
hypothesis was that non-invasively assessed airway NO
and CO production are attributable to mechanisms asso-
ciated with the above factors, and would be measurable as
altered ENO and ECO levels as a function of those genetic
manipulations. The results indicate that simple, non-inva-
sively-measured levels of ENO and ECO can be associated
with mouse genetic strain differences and non-invasively-
measured AR, as well as aging and allergic AI responses.
Methods
General
Male mice of the C57Bl6 and A/J strains, and certified
double knockout IL-10 null mutants (IL-10-/-) mice
(B6.129P2-IL-10<tmlCgn> on a C57Bl6 background)
[20] (Jackson Laboratories) were housed in a specific
pathogen-free (SPF)-barrier facility in the Division of Lab-
oratory Animal Resources Central Animal Facility, at the
University of Pittsburgh. Mice with specific targeted dis-
ruption of the inducible NOS (NOS-2) gene (iNOS-/-) and
the endothelial NOS (NOS-3) gene (eNOS-/-) [21] on a
C57Bl6 background were obtained from breeding colo-
nies grown under specific pathogen free (SPF) conditions
at the University of Pittsburgh, and housed as described
above. Mice with targeted deletion of MAP kinase kinase-
3 (MKK3-/-) and c-Jun NH2-terminal kinase 1 (JNK1-/-)
were obtained from breeders originating at Yale Univer-
sity, subsequently bred and grown under SPF conditions
at the University of Pittsburgh, housed as described above.
Littermate MKK3-sufficient mice (C57/C129) were
obtained from within these same breeding colonies and
housed as above. The A/J mouse strain was utilized for
contrast with the C57Bl6 wild type and targeted gene
knockout mice, as a strain known for its airway hyperre-
sponsiveness [22]. All mice were allowed to age to 8–10
weeks before being subjected to the protocols described
below, allowing them to grow to a size (18–25 grams)
that facilitated airway cell recovery by bronchoalveolar
lavage (BAL). All mice had constant access to Purina
mouse chow and water, ad libitum. All procedures and
protocols utilized in these studies were approved by the
University of Pittsburgh Institutional Animal Care and
Use Committee, conforming to guidelines recommended
by the National Institutes of Health and the United States
Department of Agriculture.
Exhaled Nitric Oxide and Carbon Monoxide
ENO and ECO were assessed by a multi-channel gas analyzer
(Logan 2500, Logan Research Limited, Kent, UK), whichRespiratory Research 2008, 9:45 http://respiratory-research.com/content/9/1/45
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measured ECO (sensitivity = 0.1 ppm, T90 <5 s), and ENO
(sensitivity = 0.3 ppb, T90 <0.5 s), using photometric
determination of chemiluminiscence. The same instru-
ment measured CO2 concentrations with a sensitivity of
0.1%, and a T90 of 200 ms, using the infrared absorption
principle. Unanesthetized mice were placed individually
within a closed Plexiglas chamber with a low volume
(~600 ml; Buxco, Inc.) and allowed to breathe freely, until
ambient CO2 levels measured 5%, roughly approximating
normal end-tidal CO2 (5–5.5%), at which point NO and
CO concentrations were measured (Figure 1A). The time
taken to reach this CO2 concentration was calibrated as a
function of animal mass, serving as an index of basal met-
abolic rate. Typically, the range of time was 6–13 min. for
mice weighing 18–35 g, yielding reproducible ENO and
ECO to within 7% across measurements. All measurements
were made at times when ambient air levels were typically
less than 2 ppb for NO and less than 0.5 ppm for CO (Fig-
ure 1B). Air in the chamber was sampled through a stop-
cock for 20 seconds, at a withdrawal rate of 250 ml/min,
such that approximately 83 ml was withdrawn, sufficient
to make the needed measurements within a gas sample
that constituted less than 15% of the total gas volume
within the chamber. The withdrawal rate was set by the
gas analyzer flow rate, which was always 250 ml/min for
every test. Afterwards, the mice were removed immedi-
ately from the chamber and replaced within their cages.
Airway Responses
Alterations in the enhanced pause (Penh) associated with
aerosolized methacholine (MCh) administration was uti-
lized as a measure of AR, as described previously [1].
Briefly, unanesthetized mice were placed within specially
designed small volume (~600 ml) Plexiglas chambers
equipped with transducers that monitored chamber pres-
sure alterations as a function of mouse breathing patterns
Schematics of exhaled gas setup and data Figure 1
Schematics of exhaled gas setup and data. A. Schematic of experimental setup used to measure exhaled NO and CO in mice. Expired gas from the mouse 
was sampled from small holding chamber, with an integral stopcock to allow rapid sample switching from ambient to expired air. B. Schematic representa-
tion of signals redrawn from actual signals of one individual mouse with airway inflammation. Increased NO (16–18 ppb) and CO (5–7 ppm) is apparent in 
first 10s of 20s sampling period, when sampling chamber air, as compared with low concentrations of NO (0–2 ppb) and CO (0–1 ppm) in ambient air, 
pre- and post-sampling of chamber. Additional details are in text.
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(Buxco, Inc.). Penh, a calculated parameter which is a
function of the degree of bronchoconstriction in response
to MCh, was calculated in the conventional way by a soft-
ware program (BioSystem XA, Buxco, Inc.) from amplified
expiratory pressure signals generated by the transducers
[23]. MCh dissolved in phosphate-buffered saline (pH =
7.4) was administered as an aerosol to the mice within the
chambers, by using a DeVilbiss ultrasonic nebulizer (aer-
osol droplet size = 1–5 μm), connected to an aerosol
driver and pump apparatus (Buxco, Inc.). The administra-
tion duration of each MCh concentration was 2 min., fol-
lowed by a 3 min. observation and continued data
collection period. The highest Penh value achieved during
the administration and observation periods was used as
the peak response value for each mouse.
Induction of Airway Inflammation
Mice were sensitized and aerosol challenged with ovalbu-
min (OVA), using a protocol that reliably increases total
cell numbers and eosinophils in recovered bronchoalveo-
lar lavage (BAL) fluid, similar to that previously described
[24]. Briefly, sensitization was achieved by using 0.5-ml
injections, i.p., of OVA (50 μg/ml, Sigma, Grade VI) and
alum (1 mg/ml) as a mild adjuvant, dissolved in normal
saline. A mild airway inflammation was induced in which
mice were injected twice, once on day one, and then with
a booster seven days later. On day 14, the mice were sub-
jected to a 10-minute airway allergen challenge using
OVA/saline aerosol (5 mg/ml), which was repeated three
times, during days 14 (once, 30 min.) and 15 (twice, 30
min. ea.; 4–6 hours between challenges), with subsequent
assessment on day 17.
Inhibition of NOS and HO
Neuronal/constitutive NOS (NOS-1) was inhibited in
NOS-2-/- mice by administration of S-methyl-L-thiocitrul-
line (SMTC; Alexis) injected i.p. (10 mg/kg) every other
day, over a five-day period, which included the week prior
to, and the week of, the OVA/saline aerosol challenges.
HO was inhibited using tin protoporphyrin (SnPP; Por-
phyrin Products), dissolved in either DMSO, or aqueous
1 N potassium hydroxide and pH-balanced to a value of
7.0, injected i.p. (50 μmol/kg), one day prior to aerosol
challenge.
Bronchoalveolar Lavage (BAL)
BAL was performed to verify the induction of airway
inflammation by the allergen provocation protocol. We
have found that BAL fluid returns can be diminished by
30–50% due to residual MCh-induced bronchoconstric-
tion with the assessment of AR (data not shown), there-
fore these assessments were performed in a separate group
of mice. As previously described [24], forty-eight hours
after the last aerosol challenge, the mice undergoing BAL
were anesthetized with Metofane, rapidly killed by cervi-
cal dislocation, and subjected to open-chest BAL using
sterile, endotoxin-free normal saline, to obtain airway
cells from both lungs. Differential cell counts were
obtained using Diff-Quik staining (Scientific Prod.), and
another aliquot was used for cell viability, using the
Trypan Blue exclusion method. Two- to three-hundred
cells were counted per slide to with total cell counts
expressed per body weight of mouse, to normalize for size
differences between mice; eosinophils and macrophage
numbers were expressed as percent of total cells counted.
Statistics
Statistical analyses of BAL variables were performed using
independent sample t-tests, comparing naïve and OVA
treatments within and across mouse strains. ENO and ECO
values without and with airway inflammation within and
across mouse strains were compared using independent
sample t-tests, while changes in ENO over time with induc-
tion of AI, and comparisons of AR were made with a
repeated-measures ANOVA, with post-hoc testing of dis-
creet data at specific MCh concentrations or times by Stu-
dent-Neuman Keuls analyses. In cases where the data were
assessed to be non-normally distributed, a non-paramet-
ric analog (repeated measures ANOVA on ranks) was uti-
lized, followed by a Dunnett's post-hoc test to evaluate
differences in discreet data within experimental groups.
Changes in ENO and ECO with inhibition of NOS and HO
were made with a paired t-test. Changes in ENO with age in
IL-10-/-  mice were evaluated using an iterative least-
squares non-linear regression analysis, modeled with a 3-
parameter single exponential decay curve (y = a·e-bx + c,
where y was the regression-predicted ENO at any age point
(x) on the curve, a and b were regression constants, k was
the inverse time constant of decay, i.e., 1/τ, and c was the
asymptote of decay). Changes in ENO with age in C57Bl6
mice were evaluated using linear regression (y = mx + b,
where m was the slope, and b was the y-intercept at x = 0).
The same linear regression approach was used to evaluate
ECO with age in both IL-10-/- and C57Bl6 mice. All statisti-
cal tests and regression analyses were performed using Sig-
maStat (SPSS, Inc.), in which a value of P < 0.05 was
considered significant.
Results
ENO and ECO in naïve mice
Average levels of ENO in naïve C57Bl6 mice from 8–22
weeks of age ranged from 5–7 ppb (Figure 2A). ENO levels
in naïve A/J, MKK3-/-, MKK3-sufficient (C57/C129) and
NOS-3-/- mice were not statistically different from the
C57BL6 mice, ranging from 6–9 ppb. However, ENO was
significantly elevated for IL-10-/- mice, and unexpectedly,
for NOS-2-/- mice, to levels of 8–10 and 15–17 ppb (P <
0.05), respectively. Notably, ENO levels were significantly
decreased in JNK1-/- mice. These data suggested that non-
invasively measured ENO was mouse strain and genetic-Respiratory Research 2008, 9:45 http://respiratory-research.com/content/9/1/45
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knockout dependent, prior to any experimental manipu-
lations.
Average levels of ECO in naïve C57Bl6 mice ranged from
2–2.5 ppm (Figure 2B). ECO levels in naïve IL-10-/-, JNK1-/
-, and NOS-3-/- mice were not statistically different from
the C57Bl6 mice, ranging from 1.5–2.5 ppm. However,
ECO was significantly elevated in the A/J (~3.0 ± 0.2 ppm,
P < 0.05), MKK3-/- (~4.0 ± 0.2 ppm, P < 0.05), MKK3-suf-
ficient (~3.2 ± 0.2 ppm, P < 0.05), and NOS-2-/- (~3.1 ±
0.1 ppm, P < 0.05) mice. Furthermore, ECO was signifi-
cantly increased in the MKK3-/- mice as compared to wild-
type littermate controls (~4.1 ± 0.2 vs. 3.2 ± 0.2 ppm, P <
0.05), and likewise was significantly increased in the
NOS-2-/-, as compared to NOS-3-/-, mice (3.4 ± 0.1 vs. 2.8
± 0.1 ppm, P < 0.05). Similar to ENO, these data suggested
that non-invasively measured ECO was mouse strain and
genetic-knockout dependent, prior to any experimental
manipulations.
AR in naïve mice
AR to inhaled MCh was demonstrated in naïve C57Bl6
control mice, such that Penh was significantly increased at
all concentrations ≥ 10 mg/ml (Figure 3A). Likewise,
naïve IL-10-/- mice demonstrated significant AR, which
was of decreased magnitude as compared to the IL-10-suf-
ficient wild-type C57Bl6 mice. NOS-3-/-  mice demon-
strated a trend toward increased AR at these same MCh
concentrations, which was not significantly different from
respective  0  MCh, and was significantly lower than
Airway responses to MCh (as enhanced pause; Penh) in naïve  mice of various strains Figure 3
Airway responses to MCh (as enhanced pause; Penh) in naïve 
mice of various strains. A. Means ± SE shown for strains 
C57Bl6 (filled circle, n = 12), IL-10-/- (open circle, n = 12), 
NOS-2-/- (filled triangle, n = 8) and NOS-3-/- (open triangle, n 
= 4); **P < 0.05 vs. 0 mg/ml MCh and next lowest MCh con-
centration within strain; ***P < 0.05 vs. 0 mg/ml MCh and 
next two lowest MCh concentrations within strain; vP < 0.05 
decreased vs. C57Bl6 at same MCh concentration; +P < 0.05 
NOS-2-/- vs. NOS-3-/- at given MCh concentration. B. Means 
± SE shown for strains: A/J (filled square, n = 12), MKK3-/- 
(open square, n = 10), MKK3-sufficient C57/C129 (crossed 
square, n = 10), JNK1-/- (inverted filled triangle, n = 10), as 
compared to C57Bl6, as in panel A. *P < 0.05 as compared to 
0 mg/ml MCh within strain; ^P <0.05 increased vs. C57Bl6 at 
same MCh concentration; other significance symbols as in 
panel A.
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C57Bl6 controls at MCh concentrations above 10 mg/ml
(P < 0.05). NOS-2-/- mice displayed a nearly flat AR rela-
tionship, which was likewise significantly lower (as indi-
cated by inverted carat) than control C57Bl6 mice at MCh
concentrations above 10 mg/ml (P < 0.05), and was sig-
nificantly lower than the NOS-3-/- mice at MCh concentra-
tions ≥ 10 mg/ml (P < 0.05).
Shown on a greater scale, with C57Bl6 mice for reference,
naïve A/J mice demonstrated significant AR to MCh at all
concentrations above 1 mg/ml, and this response was sig-
nificantly greater than that observed in C57Bl6 mice, at
these same concentrations (Figure 3B). Interestingly,
MKK3-/- mice likewise displayed significant AR at MCh
concentrations  ≥ 10 mg/ml, and were found to be
increased at the highest MCh concentration (50 mg/ml; P
< 0.05) as compared to C57Bl6 controls. JNK1-/- mice also
showed significant AR at 25 and 50 mg/ml, and were sig-
nificantly less than C57Bl6 mice at the highest concentra-
tion of MCh (50 mg/ml, P < 0.05). The MKK3-sufficient
littermates (C57/C129 mice) were relatively flat in MCh
response, demonstrating a small but significant increase
only at the highest MCh concentration. These non-inva-
sively obtained AR are consistent with potential mecha-
nisms dependent on airway ENO and ECO levels, indicated
by our exhaled gas measurements.
ENO and ECO as a function of age
ENO was measured in naive IL-10-/- mice (n = 234) from
ages 8 to 58 weeks (Figure 4A). The non-linear regression
demonstrated a significant curvilinear relationship of ENO
with age, beginning at a high point of 13.8 ppb (the y-
intercept at 8 weeks of age) and declining to an asymptote
of 5 ppb, by 58 weeks of age. Unlike the IL-10-/- mice, the
ENO and ECO as a function of age Figure 4
ENO and ECO as a function of age. A. ENO with age in IL-10-/- mice (n = 234) from 8–58 weeks of age. Line indicates best-fit 
exponential decay regression curve (P < 0.05), calculated as described in the Methods section. Calculated regression equation 
was: y = 5 + 12 e-0.04x, with r2 = 0.11, and y-intercept (ENO) = 13.8 ppb at 8 weeks of age. B. ENO with age in C57Bl6 mice (n = 
51) from 8–50 weeks of age, with abscissa lengthened to 58 weeks for comparison with IL-10-/- mice in panel A. Line indicates 
best-fit linear regression curve, calculated as described in the Methods section. Calculated regression equation was: y = - 0.02x 
+ 7.8, with r2 = 0.01, and y-intercept (ENO) = 7.7 ppb at 8 weeks of age. C. ECO with age in same IL-10-/- mice as in panel A. Cal-
culated regression equation was: y = - 0.002x + 3.7, with r2 = 0.0002, and y-intercept (ECO) = 3.7 ppb at 8 weeks of age. D. ECO 
with age in same C57Bl6 mice as in panel B. Calculated regression equation was: y = 0.0112x + 2.1, with r2 = 0.02, and y-inter-
cept (ECO) = 2.2 ppb at 8 weeks of age.
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naïve C57Bl6 mice tested (n = 51) had a lower y-intercept
(7.7. ppb at 8 weeks of age) and demonstrated no signifi-
cant change in ENO from ages 8–50 weeks of age, as indi-
cated by a calculated slope value that was near zero over
the age range studied (Figure 4B). These results suggest
that non-invasively measured ENO is stable with age in
naïve C57Bl6 mice, but is high and falls with age in the
absence of IL-10 and experimental manipulations.
Unlike ENO in the IL-10-/- mice, ECO was relatively constant
with age in the naïve IL-10-/- and C57Bl6 mice tested (Fig-
ures 4C and 4D). The y-intercepts at 8 weeks were signifi-
cantly different from 0 ppm ECO in each case (3.7 and 2.1,
respectively), but the slopes of the regression lines were
not significantly different from zero, suggesting no signif-
icant change over the aging interval monitored.
ENO and ECO with induction of allergic airway 
inflammation
Allergic airway inflammation, as reflected by BAL total cell
count, and macrophage and eosinophil numbers, was
produced to varying degrees in all mice with systemic sen-
sitization and airway challenge using OVA (Table 1); how-
ever, the total cell count and eosinophil responses were
minimal in NOS-2-/- mice. With allergic airway inflamma-
tion, a group of C57Bl6 mice (n = 20) followed over time,
from the naïve state, through systemic OVA sensitization
injection, and subsequent OVA aerosol airway challenge,
demonstrated a significant rise in non-invasively meas-
ured ENO over the course of the inflammation induction
protocol. Figure 5A indicates an average starting point of
nearly 7 ppb, with a significant doubling to approxi-
mately 12 (P < 0.05) and 14 (P < 0.05) ppb, at 24 and 48
hr after the final OVA aerosol challenge, followed by a
decline to approximately 10 ppb at 72 hr (n.s.). This pat-
tern was suggestive of an early to intermediate response of
ENO with induction of allergic airway inflammation, fol-
lowed by a reduction in the late-phase portion of the
inflammatory response.
Similarly, in those same mice, ECO was increased with
induction of allergic airway inflammation, rising from 2.3
ppm in the naïve state, to 2.8 ppm over the 24–72 hr time
interval after the final OVA aerosol challenge (Figure 5B).
This pattern was consistent with an early response of ECO
with induction of allergic airway inflammation, but
lacked the fall at 72 hr observed with ENO, suggesting a
lack of resolution within the same time interval as that
observed for ENO.
ENO and ECO comparisons with allergic airway 
inflammation
With allergic airway inflammation, the levels of ENO sig-
nificantly increased from 1–3-fold (P < 0.05) in C57Bl6,
A/J, MKK3-/-, MKK3-sufficient, and JNK1-/- mice (Figure
6A), when compared to ENO values from each respective
naïve strain or knockout. The numerical increase in ENO in
IL-10-/- mice suggested a similar increase, but was not sta-
tistically different from the naïve IL-10-/- ENO values. ENO
of the MKK3-/- mice with allergic airway inflammation was
greater (P < 0.05) than its MKK3-sufficient littermate con-
trol. However, as compared to both C57Bl6 and NOS-3-/-
mice, the NOS-2-/- mice demonstrated a significant reduc-
tion in ENO with allergic airway inflammation (-50%, P <
0.05), while ENO  of the NOS-3-/-  mice remained
unchanged from baseline levels and was different than the
NOS-2-/-  mice. These data suggested that different
Alterations in ENO and ECO with induction of inflammation Figure 5
Alterations in ENO and ECO with induction of inflammation. A. 
Changes in ENO with induction of airway inflammation by 
OVA treatment in C57Bl6 mice, over duration of sensitiza-
tion and challenge protocol (3 wk.). Naïve is prior to sys-
temic OVA sensitization injection, pre-challenge is after 
systemic OVA sensitization booster injection, and post-chal-
lenge times are elapsed times after 3rd OVA aerosol chal-
lenge. Values are means ± SE for n = 20 mice followed over 
time, *P < 0.05 as compared to naïve. B. Changes in ECO in 
same mice as in panel A; *P < 0.05 as compared to naïve.
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responses to allergic airway inflammation were depend-
ent on the strain or targeted gene knockout of the mice
tested, as measured with our non-invasive technique.
ECO was significantly increased ~1–2.5-fold in C57Bl6, IL-
10-/-, A/J, and JNK1-/- mice with airway inflammation (Fig-
ure 6B), as compared to respective naïve strain or knock-
out mice. No significant change in ECO was observed in
MKK3-/-, MKK3-sufficient, NOS-2-/-, and NOS-3-/- mice,
compared to their appropriate littermate controls. These
data suggested different responses of ECO as compared to
ENO, as a function of allergic airway inflammation and
mouse strain or targeted gene knockout.
Effects of NOS and HO inhibition
As noted previously in Figure 5B, systemic sensitization
with i.p. injections of OVA in untreated C57Bl6 control
mice did not significantly increase ECO, but challenge with
OVA aerosol resulted in an increase in ECO, indicating that
the rise in ECO was associated with induction of allergic
airway inflammation (Figure 7A). This increase in ECO was
attenuated in mice pretreated with SnPP to inhibit HO.
The degree of attenuation made it statistically similar to
both the non-SnPP-treated group with airway inflamma-
tion, and the non-SnPP-treated naïve controls, which sug-
gested that the value was intermediate between them.
As compared to naïve C57Bl6 mice, AR increased at the
highest concentration of MCh (50 mg/ml, P < 0.05) in
C57Bl6 mice with allergic airway inflammation due to
OVA (Figure 7B). With SnPP administration in the pres-
ence of allergic airway inflammation, AR was also elevated
at the highest concentration of MCh as compared to naïve
controls (P < 0.05), but was not statistically different from
that measured in mice treated with OVA and no SnPP.
These data were suggestive of a trend toward increased AR
with inhibition of HO in the presence of allergic airway
inflammation.
In naive NOS-2-/- mice, a significant reduction in ENO from
a median value of 22.5 ppb to 4 ppb (P  < 0.05) was
observed after chemical inhibition of neuronal/constitu-
tive NOS (I) with SMTC (Figure 8A). These declines in ENO
with SMTC administration were associated with a signifi-
cant rise in ECO from a median value of 3.1 to 4.1 ppm (P
< 0.05). Conversely, administration of SnPP to naïve
NOS-2-/- mice resulted in a decline in ECO in each of the
three mice tested, along with concomitant increases in
ENO in those same mice (Figure 8B). Statistical analyses
were not applied to those data due to the small number of
mice tested, however, the respective ECO  and ENO
responses were similar in direction and magnitude. These
data indicated that in the absence of NOS-2, inhibition of
NO production by NOS-I can result in increases in CO
levels, and that inhibition of CO production by HO may
result in increased NO levels.
AR was increased in NOS-2-/- mice with induction of aller-
gic airway inflammation by OVA (Figure 8C), which was
consistent with the reduction of ENO observed in this
group. AR was also increased in naive NOS-2-/- mice with
inhibition of HO by SnPP. However, inhibition of NOS-I
with SMTC did not alter AR to MCh as compared to naive
NOS-2-/- mice, remaining flat across MCh concentrations.
These data suggested that NO-inhibition driven changes
in ECO may be associated with alterations in AR to MCh.
Discussion
Our results indicate that a simple non-invasive technique
utilized for measurement of ENO and ECO can be associ-
Table 1: Bronchoalveolar lavage cell counts in various strains of mice.
Strain Treatment Total cells (× 104 /g) Macrophages (%) Eosinophils (%)
C57Bl6 -OVA 1.4 ± 0.1 99 ± 1 0
+OVA 8.5 ± 1.6* 51 ± 14* 48 ± 14*
IL-10-/- -OVA 0.5 ± 0.1 99 ± 1 0
+OVA 4.5 ± 1.0* 39 ± 5* 45 ± 8*
A/J -OVA 0.5 ± 0.1 96 ± 1 0
+OVA 5.2 ± 0.5* 16 ± 3* 79 ± 4*
MKK3-/- -OVA 0.5 ± 0.1 91 ± 4 0
+OVA 2.3 ± 0.5* 66 ± 7* 44 ± 5*
C57/C129 -OVA 0.8 ± 0.1 93 ± 2 0
+OVA 2.1 ± 0.3* 96 ± 2 1 ± 1
JNK1-/- -OVA 1.2 ± 0.4 93 ± 3 1 ± 1
+OVA 0.9 ± 0.3 24 ± 8* 20 ± 8*
NOS-2-/- -OVA 0.2 ± 0.1 38 ± 17 0
+OVA 0.3 ± 0.1 75 ± 14* 1 ± 1
-OVA = naïve; +OVA = airway inflammation; total cell counts expressed per gram body weight; values are means ± SE; *P < 0.05 +OVA vs. -OVA 
for each respective strain; n = 3–7 per group.Respiratory Research 2008, 9:45 http://respiratory-research.com/content/9/1/45
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ated with physiological responses in specific strains of
mice, and with specific manipulation of important induc-
ible enzymes, like NOS and HO. This technique also
allowed collection of repeated measurements over time,
making it useful in determining alterations in ENO and ECO
with induction of acute experimental airway inflamma-
tion.
Alterations in ENO
The levels of non-invasively measured ENO  in naïve
C57Bl6 and A/J mice are consistent with prior findings in
mice using similar, but more complicated measurement
techniques using flow-through null-gas or gas scrubbers
[17,18]. The exceptions to those levels were our findings
in IL-10-/-, NOS-2-/-, and JNK1-/- mice. A high level of ENO
would be expected in IL-10-/- mice [24], because IL-10 is a
natural suppressor of NOS-2 induction, and consequent
NO production [25]. However, the elevated level of ENO in
the NOS-2-/- mice was an unexpected finding, based on
one prior report [26], and given that the major inducible
enzyme producing NO was missing. Prior reports have
alternatively suggested that a significant amount of NO in
the murine airway is due to the action of NOS-3 [27], or
NOS-1 [26]. Selective inhibition of NOS-1 in the NOS-2-/
- mice with SMTC resulted in a decrease in ENO toward lev-
els seen in the other strains, which would lead us to con-
clude that upregulation of NOS-1 was a likely source of
the increased ENO in the NOS-2-/- mice.
Changes in ECO and AR with inhibition of HO Figure 7
Changes in ECO and AR with inhibition of HO. A. Exhaled 
CO (ECO) changes with inhibition of heme-oxygenase by tin 
protoporphyrin (SnPP) without induction of airway inflamma-
tion (OVA, i.p.) and with airway inflammation (+OVA aero-
sol), in C57Bl6 mice, expressed as fraction of naïve (-OVA) 
controls (dashed line average = 2.3 ppm ECO, as shown in Fig-
ure 2A). *P < 0.05 vs. both naïve baseline and respective 
strain OVA sensitized-only (i.p.) group; n = 4/bar. B. Airway 
responses (Penh) to methacholine (MCh) aerosol in C57Bl6 
mice either naïve (filled square ; n = 11); with airway inflam-
mation (+OVA) +DMSO vehicle (filled circle; n = 6); or with 
airway inflammation + SnPP/DMSO (inverted filled triangle; n 
= 4); *P < 0.05 increased vs. naïve at same MCh concentra-
tion.
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Comparisons of ENO and ECO across mouse strains Figure 6
Comparisons of ENO and ECO across mouse strains. A. 
Exhaled NO (ENO) with airway inflammation, expressed as 
fold change as compared to ENO in respective-strain naïve 
mice. *P < 0.05 vs. respective-strain naïve mice controls; +P < 
0.05 MKK3-/- vs. MKK3-sufficient (C57/C129) controls, and P 
< 0.05 NOS-2-/- vs. NOS-3-/- mice. Values are means ± SE; 
strain(n) = C57Bl6(8), IL-10-/-(12), A/J(12), MKK3-/-(11), C57/
C129(6), JNK1-/-(4), NOS-2-/-(8), NOS-3-/-(14). B. Changes in 
exhaled CO (ECO) with induction of airway inflammation, 
expressed as fold change as compared to ECO in respective-
strain mice. Values are means ± SE, with significance and n as 
in Panel A.
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Repeated non-invasive measures of ENO in C57Bl6 mice
from their naïve state to induction of airway inflamma-
tion indicated a pattern of increase consistent with an
early inflammatory response that resolved over time.
While not unexpected, those data demonstrate that our
simple method can follow ENO as a biomarker of the aller-
gic airway inflammatory response in wild-type C57Bl6
mice, similar to humans [28]. An unexpected finding was
that administration of OVA resulted in decreased ENO in
NOS-2-/-  mice, previously measured to be high when
naive (Figures 2 and 6), coupled with the lack of cell
recruitment and eosinophilia (Table 1). There is some
precedent for these responses, reported as decreased
nitrite and nitrate [29], and a lack of eosinophilia in BAL
fluid of NOS-2-/- mice with allergic airway inflammation,
as compared to C57Bl6 mice [27,30]. However, that prec-
edent has not been uniform, in that at least one report
indicated no differences in allergic airway eosinophilia
Modulation of ENO, ECO, and AR in NOS-2-/- mice Figure 8
Modulation of ENO, ECO, and AR in NOS-2-/- mice. A. Changes in exhaled NO (ENO; open circle) and CO (ECO; filled circle) in 
NOS-2-/- mice (n = 4) 48 hr. after administration of S-methyl-L-thiocitrulline (SMTC). Open bar indicates median ENO value, 
black bar indicates median ECO value; *P < 0.05 vs. -SMTC. B. Changes in exhaled NO (ENO; open circle) and CO (ECO; filled 
circle) in NOS-2-/- mice (n = 3) 48 hr. after administration of tin protoporphyrin (SnPP). Symbols and bars as in panel A. C. Air-
way responses (Penh) to methacholine (MCh) aerosol in naïve NOS-2-/- mice treated with SMTC (open square n = 4) or SnPP 
(inverted open triangle; n = 3), and with allergic airway inflammation (+OVA, filled triangle, n = 8) as compared to naive NOS-
2-/- mice with no treatment (open triangle; n = 8). *P < 0.05 vs. 0 mg/ml MCh, ^P < 0.05 vs. naive at same MCh concentration.
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between C57Bl6 and NOS-2-/- mice [31]. Furthermore,
NOS-3 overexpression in mice has been associated with
decreased allergic inflammation-associated airway eosi-
nophilia [29]; therefore, its compensatory upregulation in
NOS-2-/- mice could explain our findings.
Associations of ENO with AR
In several instances, e.g., C57Bl6 and IL-10-/- mice, the
respective measured low and high ENO levels were consist-
ent with the observed AR to MCh, supporting the idea that
NO may act as a bronchodilator [8]. The high level of ENO
in the NOS-2-/- mice was unexpected, but again, a con-
comitant low level of AR was consistent with NO counter-
acting the effects of MCh on AR. Those findings were
consistent with prior findings in NOS-1-/- mice [31], sup-
porting that the absence or inhibition of one or more
NOS isoforms can influence non-invasively measured AR
to MCh. Furthermore, the unexpected reduction in ENO
with allergic airway inflammation in the NOS-2-/- mice
appears to fit with the increase in AR we observed (Figure
8C), and is consistent with elevations reported in NOS-2-
/- mice given OVA, using a more invasive bronchospasm
assessment method [27,30]. However, it also has been
reported that NOS-3 may be a significant factor determin-
ing AR in mice [27]. Although reasonably selective for
NOS-1, SMTC is also known to inhibit NOS-3 [32]. There-
fore, we cannot rule out the possibility that the effects of
SMTC were not solely on NOS-1, but also may have
involved inhibition of NOS-3, resulting in the AR
responses we observed. The increased AR demonstrated
by the naive NOS-3-/- mice in comparison with the naive
NOS-2-/- mice (Figure 3) would suggest that compensatory
NOS-3 upregulation was responsible for the relatively flat
AR relationship in the NOS-2-/- mice. Furthermore, the
lack of effect of SMTC on AR in the face of significantly
reduced ENO levels in the NOS-2-/- mice (Figure 8) suggests
that NOS-1 was not acting to suppress AR with genetic
deletion of NOS-2.
ENO with Aging in the Absence of IL-10
In our prior studies of IL-10-/- mice demonstrating ele-
vated ENO values, the mice that were observed with symp-
toms of rectal prolapse, diarrhea, and failure to gain
weight, were routinely excluded from consideration
[24,33,34], due to the tendency of IL-10-/- mice to develop
enterocolitis with age [20]. However, throughout those
studies and the present one, we noted either a lack of, or
long-delayed (>22 weeks of age), onset of those outward
symptoms in some groups of IL-10-/- mice, allowing them
to live beyond their normal life expectancy, making us
curious about their ENO levels as they aged. This provided
an opportunity for us to determine the relationship of age
and ENO, in a mammalian system lacking IL-10, in com-
parison with their wild-type IL-10 sufficient C57Bl6 coun-
terparts. Our findings suggest that the initially high ENO
associated with a lack of IL-10 declines with age.
While the typical inflammation-associated symptoms
were either absent or marginally discernable in aging IL-
10-/- mice in the present studies, it could be argued that
there were either undetermined levels of internal inflam-
mation not outwardly apparent, or that those mice were
somehow protected from the effects of diffuse inflamma-
tion, and specifically those occurring within the gastro-
intestinal tract, that allowed their continuation as survi-
vors. Our experiments thus far do not allow us to discern
which of these possibilities occurred. However, prior stud-
ies suggest the potential for compensatory mechanisms
[27,31,35,36] that may have resulted in less inflammation
and therefore, decreased NO production, which would be
consistent with our findings.
Alterations of ECO
ECO was similar in C57Bl6, IL-10-/-, JNK1-/-, and NOS-3-/-
mice, being most strongly elevated in naïve MKK3-/- mice,
perhaps as a result of disruption of the normal MAPK
pathway through which CO is known to signal [37].
Therefore, while ECO levels appear to be associated with
airway inflammation and asthma severity [16], our data
support the idea that a portion of this association may be
through the involvement of MAPK pathways modulated
as part of the process of inflammation. Elevated levels of
ECO observed in naïve A/J and NOS-2-/- mice are difficult
to interpret within this MAPK-associated construct, but
suggest other mechanisms modulating ECO that require
investigation within those mouse strains. Following
development of airway inflammation, several strains of
mice (MKK3-/-, NOS-2-/-, and NOS-3-/-) had no measura-
ble changes in ECO, in contrast to many others. In the case
of the MAPK, those data would suggest that MKK3 is a crit-
ical MAPK that promotes an airway CO response to airway
inflammation, whereas JNK1 is not. Furthermore, our
data suggest that, similar to ENO, ECO also tracks develop-
ment of acute allergic airway inflammation in C57Bl6
mice, as has been reported in humans [11], making Eco a
potentially useful biomarker in mouse models of asthma
characteristics.
Associations of ECO with AR
Exogenously administered CO has been shown to func-
tion as a bronchodilator and to reduce AR in guinea pigs
and mice [1,3], thus these properties might likewise be
expected of endogenous CO in the airway. The reduction
of ECO with SnPP treatment in C57Bl6 mice, coupled with
the associated increase in AR (Figure 7), support this con-
cept. An increase in AR was also observed with SnPP treat-
ment and reduction of ECO in NOS-2-/- mice, while ENO
increased (Figure 8). Taken together, these data suggest
that airway CO may be produced in high amounts as aRespiratory Research 2008, 9:45 http://respiratory-research.com/content/9/1/45
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bronchoprotective agent in some strains of mice, and that
its affects may be dependent on its balance with airway
NO production.
Critique of Methods
One of the primary goals of this study was to make simple
non-invasive assessments of airway NO and CO, as ENO
and ECO, and to correlate them with differences in AR,
likewise measured non-invasively, as Penh. The advan-
tages of the techniques utilized in the present study were
their non-invasive assessment, repeatability, and minimal
manipulation of unanesthetized mice. The procedures
were well-tolerated and resulted in no discernable imme-
diate or long-lasting effects, either outwardly, or in the
variables measured.
The use of Penh as an index of MCh-driven airway con-
striction, or its associated events, has been questioned
recently, due to dissociations in airway resistance and
Penh measurements reported under some conditions, in
certain strains such as BALB/c and C57Bl6 mice [38]. We
have found previously that, in our hands, Penh does cor-
relate with allergic AI-driven changes in airway resistance
(as measured by invasive techniques), in strains we have
tested, such as C57Bl6 and A/J mice [1,33]. Furthermore,
we have observed that Penh measurements of MCh-asso-
ciated airway responses match MCh-stimulated airway
smooth muscle responses of tracheal rings in vitro, in
C57Bl6 and IL-10-/- mice [33]. Moreover, our results were
corroborated by the studies of Justice, et al., [39] on
C57Bl6 and IL-10-/- mice, in which the patterns of MCh-
associated Penh measurements tracked both airway resist-
ance and tracheal ring tension measurements in those
same mice. Finally, our Penh data indicating increments
in AR in NOS-2-/- mice given OVA are consistent with a
prior report in NOS-2-/-  mice using a more invasive
approach to measure responses to MCh [27,30]. Although
the magnitude of increment reported in that study
appeared greater, that magnitude difference could be
explained by their strong OVA challenge protocol, which
administered OVA aerosol 12 times over 6 days, as com-
pared to our mild challenge protocol. Thus, those prior
demonstrations of applicability, coupled with the goals of
the present study, which were to determine associations
between non-invasively measured variables, can be con-
sidered to meet the requirements for the utilization of
Penh, as suggested by De Lorme and Moss [40].
A 3-parameter single exponential decay curve was utilized
to assess the relationship of ENO with age in IL-10-/- mice,
whereas a simple linear regression was utilized for the
C57Bl6 mice, based on the visual appearance of the data
in each case. For completeness, a simple linear regression
was also performed on data from the IL-10-/- mice, which
yielded a similar y-intercept at 8 weeks of age (ENO = 14.1
ppb), and a similar regression correlation coefficient (R2 =
0.11), as compared to the exponential approach. A shal-
low, but significant negative slope (-0.2 ppb/week; P <
0.05) was obtained with the linear method, consistent
with the exponential decay using the other method. It
must be noted that although we obtained statistically sig-
nificant regressions for ENO vs. age for mice missing IL-10,
the correlation coefficient indicates that age accounts for
just over 10% of the decline in ENO, i.e, nearly 90% of the
decline may be attributable to other factors that may or
may not be associated with age, per se. Even so, these data
represent the first attempt to characterize ENO with age in
mice, which was observed to be low and unchanging in
wild-type C57Bl6 mice, and initially high and declining,
when IL-10 is missing. Further study is necessary to iden-
tify the factors behind these relationships.
Conclusion
Our ENO and AR findings are generally consistent with
compensatory physiologic alterations occurring in NOS-
2-/- mice [29,30], that NOS-1 can contribute significantly
to the measured ENO level [26], and that NOS-3 may con-
tribute less to ENO, but may have an influence on AR [31].
Therefore, our simple, non-invasively-measured ENO and
ECO data indicate that those measures can be used as
biomarkers of inflammation kinetics, and potential air-
way physiologic alterations when critical NO- and CO-
producing enzymes are missing or inhibited.
List of Abbreviations
ANOVA: analysis of variance; AI: airway inflammation;
AR: airway responses; BAL: broncheoalveolar lavage; CO:
carbon monoxide; DMSO: dimethyl sulfoxide; ENO:
exhaled nitric oxide; ECO: exhaled carbon monoxide; HO:
heme-oxygenase; HO-1: heme-oxygenase-1; IL-10: inter-
leukin-10; MCh: methacholine; JNK-1: c-jun activated
kinase 1; MAP:  mitogen-activated protein kinase; MKK3:
MAP kinase kinase 3; NO: nitric oxide; NOS: nitric oxide
synthase; NOS-1: neuronal nitric oxide synthase; NOS-2:
inducible nitric oxide synthase; NOS-3: endothelial nitric
oxide synthase; OVA: ovalbumin; Penh: enhanced pause;
ppb: parts per billion; ppm: parts per million; SMTC: S-
methionyl-L-thiocitrulline; SnPP: tin protoporphyrin;
SPF: specific pathogen free
Competing interests
The authors declare that they have no competing interests.
Authors' contributions
JMS participated in the development of the non-invasive
technique for measuring ENO and ECO, direction of the gas
micro-analyzer utilization and maintenance, analysis of
the data, and helped to draft the manuscript, AMKC pro-
vided funds for the study, provided the gas micro-ana-
lyzer, assisted with data interpretation, and helped to draftRespiratory Research 2008, 9:45 http://respiratory-research.com/content/9/1/45
Page 13 of 14
(page number not for citation purposes)
the manuscript, WJC provided funds for the study,
assisted with data interpretation, and helped to draft the
manuscript, BTA provided laboratory facilities and equip-
ment, supervised and directed the study and technical
support staff, participated in development of the non-
invasive technique for measuring ENO and ECO, assisted
with data interpretation and analyses, and helped to draft
the manuscript. All authors read and approved the final
manuscript.
Acknowledgements
This study was supported by funding from grants from the NIH (HL-63738 
and AI-42365), the American Respiratory Alliance of Western Pennsylva-
nia, and Merck, Inc. All responsibility for the study design, data collection, 
analysis, and interpretation, as well as the writing and decision to submit the 
manuscript is due to the authors and not the funding organizations. The 
authors thank He-Liang Liu, Emeka Ifedigbo, Lauryn Tait, Amber Gligonic, 
Jesse L. Parks, IV, and Barbara Dixon-McCarthy for their technical assist-
ance with various aspects of these studies. We also thank Dr. Timothy Bil-
liar for provision of the NOS-2 and NOS-3 knockout mice, and Dr. Richard 
A. Flavell for provision of the MKK3 controls, MKK3 and JNK-1 knockout 
mice utilized in these studies.
References
1. Ameredes BT, Otterbein LE, Kohut LK, Gligonic AL, Calhoun WJ,
Choi AM: Low-dose carbon monoxide reduces airway hyper-
responsiveness in mice.  American journal of physiology 2003,
285(6):L1270-6.
2. Palmer R, Ashton D, Moncada S: Vascular endothelial cells syn-
thesize nitric oxide from L-arginine.  Nature 1988, 333:664-666.
3. Cardell LO, Ueki IF, Stjarne P, Agusti C, Takeyama K, Linden A, Nadel
JA: Bronchodilatation in vivo by carbon monoxide, a cyclic
GMP related messenger.  British journal of pharmacology 1998,
124(6):1065-1068.
4. Komuro T, Borsody MK, Ono S, Marton LS, Weir BK, Zhang ZD, Paik
E, Macdonald RL: The vasorelaxation of cerebral arteries by
carbon monoxide.  Exp Biol Med (Maywood) 2001, 226(9):860-865.
5. Kacmarek RM, Ripple R, Cockrill BA, Bloch KJ, Zapol WM, Johnson
DC: Inhaled nitric oxide. A bronchodilator in mild asthmatics
with methacholine-induced bronchospasm.   Am J Respir Crit
Care Med 1996, 153(1):128-135.
6. Dugo L, Marzocco S, Mazzon E, Di Paola R, Genovese T, Caputi AP,
Cuzzocrea S: Effects of GW274150, a novel and selective inhib-
itor of iNOS activity, in acute lung inflammation.  British journal
of pharmacology 2004, 141(6):979-987.
7. Koarai A, Ichinose M, Sugiura H, Tomaki M, Watanabe M, Yamagata
S, Komaki Y, Shirato K, Hattori T: iNOS depletion completely
diminishes reactive nitrogen-species formation after an
allergic response.  Eur Respir J 2002, 20(3):609-616.
8. Tenhunen R H.S. Marver, and R. Schmidt.: The enzymatic catabo-
lism of hemoglobin: stimulation of microsomal heme oxyge-
nase by hemin.  J Lab Clin Med 1970, 75:410-421.
9. Dweik RA, Comhair SA, Gaston B, Thunnissen FB, Farver C, Thomas-
sen MJ, Kavuru M, Hammel J, Abu-Soud HM, Erzurum SC: NO
chemical events in the human airway during the immediate
and late antigen-induced asthmatic response.  Proceedings of
the National Academy of Sciences of the United States of America 2001,
98(5):2622-2627.
10. Kharitonov SA, Yates DH, Barnes PJ: Inhaled glucocorticoids
decrease nitric oxide in exhaled air of asthmatic patients.
American journal of respiratory and critical care medicine 1996,
153(1):454-457.
11. Paredi P, Leckie MJ, Horvath I, Allegra L, Kharitonov SA, Barnes PJ:
Changes in exhaled carbon monoxide and nitric oxide levels
following allergen challenge in patients with asthma.  Eur
Respir J 1999, 13(1):48-52.
12. Yamaya M, Sekizawa K, Ishizuka S, Monma M, Sasaki H: Exhaled car-
bon monoxide levels during treatment of acute asthma.  Eur
Respir J 1999, 13(4):757-760.
13. Zayasu K, Sekizawa K, Okinaga S, Yamaya M, Ohrui T, Sasaki H:
Increased carbon monoxide in exhaled air of asthmatic
patients.  Am J Respir Crit Care Med 1997, 156(4 Pt 1):1140-1143.
14. Kharitonov SA, Donnelly LE, Montuschi P, Corradi M, Collins JV,
Barnes PJ: Dose-dependent onset and cessation of action of
inhaled budesonide on exhaled nitric oxide and symptoms in
mild asthma.  Thorax 2002, 57(10):889-896.
15. Khatri SB, Ozkan M, McCarthy K, Laskowski D, Hammel J, Dweik RA,
Erzurum SC: Alterations in exhaled gas profile during aller-
gen-induced asthmatic response.  Am J Respir Crit Care Med 2001,
164(10 Pt 1):1844-1848.
16. Yamaya M, Hosoda M, Ishizuka S, Monma M, Matsui T, Suzuki T, Seki-
zawa K, Sasaki H: Relation between exhaled carbon monoxide
levels and clinical severity of asthma.  Clin Exp Allergy 2001,
31(3):417-422.
17. Kenyon NJ, van der Vliet A, Schock BC, Okamoto T, McGrew GM,
Last JA: Susceptibility to ozone-induced acute lung injury in
iNOS-deficient mice.  American journal of physiology 2002,
282(3):L540-5.
18. Weicker S, Karachi TA, Scott JA, McCormack DG, Mehta S: Nonin-
vasive measurement of exhaled nitric oxide in a spontane-
ously breathing mouse.   Am J Respir Crit Care Med 2001,
163(5):1113-1116.
19. Dercho RA, Nakatsu K, Wong RJ, Stevenson DK, Vreman HJ: Deter-
mination of in vivo carbon monoxide production in labora-
tory animals via exhaled air.  J Pharmacol Toxicol Methods 2006,
54(3):288-295.
20. Kuhn R, Lohler J, Rennick D, Rajewsky K, Muller W: Interleukin-10-
deficient mice develop chronic enterocolitis.  Cell 1993,
75(2):263-274.
21. MacMicking JD, Nathan C, Hom G, Chartrain N, Fletcher DS, Trum-
bauer M, Stevens K, Xie QW, Sokol K, Hutchinson N, et al.: Altered
responses to bacterial infection and endotoxic shock in mice
lacking inducible nitric oxide synthase.  Cell 1995,
81(4):641-650.
22. Wills-Karp M, Ewart SL: The genetics of allergen-induced air-
way hyperresponsiveness in mice.  American journal of respiratory
and critical care medicine 1997, 156(4 Pt 2):S89-96.
23. Hamelmann E, Schwarze J, Takeda K, Oshiba A, Larsen GL, Irvin CG,
Gelfand EW: Noninvasive measurement of airway responsive-
ness in allergic mice using barometric plethysmography.  Am
J Respir Crit Care Med 1997, 156:766-775.
24. Ameredes BT, Zamora R, Sethi JM, Liu HL, Kohut LK, Gligonic AL,
Choi AM, Calhoun WJ: Alterations in nitric oxide and cytokine
production with airway inflammation in the absence of IL-10.
J Immunol 2005, 175(2):1206-1213.
25. Cunha FQ, Moncada S, Liew FY: Interleukin-10 (IL-10) inhibits
the induction of nitric oxide synthase by interferon-gamma
in murine macrophages.  Biochem Biophys Res Commun 1992,
182(3):1155-1159.
26. De Sanctis GT, Mehta S, Kobzik L, Yandava C, Jiao A, Huang PL, Dra-
zen JM: Contribution of type I NOS to expired gas NO and
bronchial responsiveness in mice.  The American journal of physiol-
ogy 1997, 273(4 Pt 1):L883-8.
27. Feletou M, Lonchampt M, Coge F, Galizzi JP, Bassoullet C, Merial C,
Robineau P, Boutin JA, Huang PL, Vanhoutte PM, Canet E: Regula-
tion of murine airway responsiveness by endothelial nitric
oxide synthase.  American journal of physiology 2001,
281(1):L258-67.
28. Kharitonov SA, O'Connor BJ, Evans DJ, Barnes PJ: Allergen-
induced late asthmatic reactions are associated with eleva-
tion of exhaled nitric oxide.  Am J Respir Crit Care Med 1995,
151(6):1894-1899.
29. Ten Broeke R, De Crom R, Van Haperen R, Verweij V, Leusink-Muis
T, Van Ark I, De Clerck F, Nijkamp FP, Folkerts G: Overexpression
of endothelial nitric oxide synthase suppresses features of
allergic asthma in mice.  Respiratory research 2006, 7:58.
30. Xiong Y, Karupiah G, Hogan SP, Foster PS, Ramsay AJ: Inhibition of
allergic airway inflammation in mice lacking nitric oxide syn-
thase 2.  J Immunol 1999, 162(1):445-452.
31. De Sanctis GT, MacLean JA, Hamada K, Mehta S, Scott JA, Jiao A, Yan-
dava CN, Kobzik L, Wolyniec WW, Fabian AJ, Venugopal CS, Grase-
mann H, Huang PL, Drazen JM: Contribution of nitric oxide
synthases 1, 2, and 3 to airway hyperresponsiveness and
inflammation in a murine model of asthma.  The Journal of
experimental medicine 1999, 189(10):1621-1630.Publish with BioMed Central    and   every 
scientist can read your work free of charge
"BioMed Central will be the most significant development for 
disseminating the results of biomedical research in our lifetime."
Sir Paul Nurse, Cancer Research UK
Your research papers will be:
available free of charge to the entire biomedical community
peer reviewed and published  immediately upon acceptance
cited in PubMed and archived on PubMed Central 
yours — you keep the copyright
Submit your manuscript here:
http://www.biomedcentral.com/info/publishing_adv.asp
BioMedcentral
Respiratory Research 2008, 9:45 http://respiratory-research.com/content/9/1/45
Page 14 of 14
(page number not for citation purposes)
32. Furfine ES, Harmon MF, Paith JE, Knowles RG, Salter M, Kiff RJ, Duffy
C, Hazelwood R, Oplinger JA, Garvey EP: Potent and selective
inhibition of human nitric oxide synthases. Selective inhibi-
tion of neuronal nitric oxide synthase by S-methyl-L-thioc-
itrulline and S-ethyl-L-thiocitrulline.  The Journal of biological
chemistry 1994, 269(43):26677-26683.
33. Ameredes BT, Sethi JM, Liu HL, Choi AM, Calhoun WJ: Enhanced
nitric oxide production associated with airway hyporespon-
siveness in the absence of IL-10.  American journal of physiology
2005, 288(5):L868-73.
34. Ameredes BT, Zamora R, Gibson KF, Billiar TR, Dixon-McCarthy B,
Watkins S, Calhoun WJ: Increased nitric oxide production by
airway cells of sensitized and challenged IL-10 knockout
mice.  Journal of leukocyte biology 2001, 70(5):730-736.
35. Cook S, Vollenweider P, Menard B, Egli M, Nicod P, Scherrer U:
Increased eNO and pulmonary iNOS expression in eNOS
null mice.  Eur Respir J 2003, 21(5):770-773.
36. Biecker E, Neef M, Sagesser H, Shaw S, Koshy A, Reichen J: Nitric
oxide synthase 1 is partly compensating for nitric oxide syn-
thase 3 deficiency in nitric oxide synthase 3 knock-out mice
and is elevated in murine and human cirrhosis.  Liver Int 2004,
24(4):345-353.
37. Otterbein LE, Otterbein SL, Ifedigbo E, Liu F, Morse DE, Fearns C,
Ulevitch RJ, Knickelbein R, Flavell RA, Choi AM: MKK3 mitogen-
activated protein kinase pathway mediates carbon monox-
ide-induced protection against oxidant-induced lung injury.
The American journal of pathology 2003, 163(6):2555-2563.
38. Lundblad LK, Irvin CG, Adler A, Bates JH: A reevaluation of the
validity of unrestrained plethysmography in mice.  J Appl Phys-
iol 2002, 93(4):1198-1207.
39. Justice JP, Shibata Y, Sur S, Mustafa J, Fan M, Van Scott MR: IL-10
gene knockout attenuates allergen-induced airway hyperre-
sponsiveness in C57BL/6 mice.  American journal of physiology
2001, 280(2):L363-8.
40. DeLorme MP, Moss OR: Pulmonary function assessment by
whole-body plethysmography in restrained versus unre-
strained mice.   J Pharmacol Toxicol Methodsds 2002, 47(1):1-10.